NLM Logo

BH-AC-DMP protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
BH-AC-DMP protocol
Unique ID
C046633
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C046633
Entry Term(s)
AML89 protocol
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine / *analogs & derivatives
Daunorubicin
Prednisolone
Mercaptopurine
Frequency
39
Note
chemotherapy protocol consisting of N(4)-behenoyl-ara-C, daunorubicin, 6-mercaptopurine & prednisolone; the induction phase of JALSG AML89 protocol
Source
Rinsho Ketsueki 1985;26(4):494
Date of Entry
1985/10/30
Revision Date
2013/11/06
BH-AC-DMP protocol Preferred
page delivered in 0.004s